<DOC>
	<DOCNO>NCT02351622</DOCNO>
	<brief_summary>The investigator undertake multicentre , randomise control trial 120 adult newly diagnose ITP 5 medical center China . Part participants randomly select receive caffeic acid tablet combine dexamethasone part select receive high-dose dexamethasone treatment . Platelet count , bleed symptom evaluate treatment . Adverse event also record throughout study .</brief_summary>
	<brief_title>Caffeic Acid Tablets Second-line Therapy ITP</brief_title>
	<detailed_description>All participant ' platelet count monitor weekly . Response evaluate 3 , 6 12 month treatment . If participant get complete response response 3 month , would quit trail .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Caffeic acid</mesh_term>
	<criteria>1 . Meet diagnostic criterion immune thrombocytopenia 2 . Untreated hospitalized patient , may male female , age 18 ~ 80 year 3 . To show platelet count &lt; 30 * 10^9/L , bleed manifestation 4 . Willing able sign write informed consent 1 . Received chemotherapy anticoagulant drug affect platelet count within 3 month screen visit 2 . Received secondline ITPspecific treatment ( eg , cyclophosphamide , 6mercaptopurine , vincristine , vinblastine , etc ) within 3 month screen visit 3 . Received highdose steroid IVIG 3 week prior start study 4 . Current HIV infection hepatitis B virus hepatitis C virus infection 5 . Severe medical condition ( lung , hepatic renal disorder ) chronic ITP . Unstable uncontrolled disease condition relate impacting cardiac function ( e.g. , unstable angina , congestive heart failure , uncontrolled hypertension cardiac arrhythmia ) 6 . Female patient nurse pregnant , may pregnant , contemplate pregnancy study period 7 . Have know diagnosis autoimmune disease , establish medical history laboratory finding positive result determination antinuclear antibody , anticardiolipin antibody , lupus anticoagulant direct Coombs test 8 . Patients deem unsuitable study investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>